Skip to content

Zoetis ZTS International — Revenue

Other segment segments

U.S.
$1.09B-7.9%

Similar metrics at other companies

Groupon, Inc. logo
GRPNInternational — Revenue
$27.29M+4.7%
MGN
MGNIInternational — Revenue
$41.08M+5.4%
Mistras Group logo
MGInternational — Revenue
$36.29M+9.3%
SI-BONE, Inc. logo
SIBNInternational — Revenue
$3.29M+33.9%
Elanco Animal Health Inc. logo
ELANInternational — Revenue
$766M+19.9%
Dropbox logo
DBXInternational — Revenue
$277.9M+3.6%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's international — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's international — revenue?
Zoetis (ZTS) reported international — revenue of $1.15B in Q1 2026.
How has Zoetis's international — revenue changed year-over-year?
Zoetis's international — revenue increased by 16.6% year-over-year, from $985M to $1.15B.
What is the long-term trend for Zoetis's international — revenue?
Over 4 years (2021 to 2025), Zoetis's international — revenue has grown at a 3.7% compound annual growth rate (CAGR), from $3.65B to $4.23B.
What does international — revenue mean?
Represents the total gross sales generated by the company's operations outside of its primary domestic market. This metric captures the scale and market penetration of the firm's animal health products, including vaccines and parasiticides, across diverse international regulatory environments.